Anthera Pharmaceuticals Inc Contracts & Agreements
108 Contracts & Agreements
- Business Finance (30 contracts)
- Business Operations (4)
- Human Resources (23)
- Intellectual Property (1)
- Real Estate (2)
- Uncategorized (48)
- Letter Agreement between Anthera Pharmaceuticals, Inc. and Craig Thompson, dated June 15, 2018 (Filed With SEC on June 18, 2018)
- Amended and Restated Employment Agreement by and between the Company and Craig Thompson, dated January 5, 2018 (Filed With SEC on March 5, 2018)
- Amended and Restated Employment Agreement by and between the Company and May Liu, dated January 5, 2018 (Filed With SEC on March 5, 2018)
- Employment Agreement by and between the Company and William Shanahan, M.D., dated January 5, 2018 (Filed With SEC on March 5, 2018)
- Employment Agreement by and between the Company and Renee Martin, Ph.D., dated January 5, 2018 (Filed With SEC on March 5, 2018)
- Employment Agreement by and between the Company and Patrick Murphy, dated January 5, 2018 (Filed With SEC on March 5, 2018)
- Termination of Pleasanton Office lease, dated February 28, 2018 (Filed With SEC on March 5, 2018)
- Securities Purchase Agreement, dated October 23, 2017, by and among the Company and the Purchasers (Filed With SEC on October 25, 2017)
- Registration Rights Agreement, dated October 23, 2017, by and among the Company and the Purchasers (Filed With SEC on October 25, 2017)
- Form of Warrant to Purchase Common Stock (Filed With SEC on October 25, 2017)
- Sublease Agreement by and between the Company and NewRT, dated as of July 20, 2017 (Filed With SEC on August 9, 2017)
- PURCHASE AGREEMENT (Filed With SEC on June 19, 2017)
- 30,000,000 Shares of Common Stock ($0.001 Par Value) and Warrants to Purchase up to60,000,000 Shares of Common Stock Anthera Pharmaceuticals, Inc. Common Stock EQUITYUNDERWRITING... (Filed With SEC on March 16, 2017)
- [FORM OF WARRANT 5 YEAR TRANCHE] (Filed With SEC on March 16, 2017)
- [FORM OF WARRANT 6 MONTH TRANCHE] (Filed With SEC on March 16, 2017)
- [remainder of page left blank intentionally.] (Filed With SEC on March 16, 2017)
- WARRANT AGREEMENT ToPurchase Shares of the Common Stock of ANTHERA PHARMACEUTICALS, INC. Dated as of September 12, 2016 (the Effective Date) (Filed With SEC on September 12, 2016)
- SUBSCRIPTION AGREEMENT (Filed With SEC on September 12, 2016)
- Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward, California 94545 (Filed With SEC on April 29, 2016)
- ANTHERA PHARMACEUTICALS,INC. $25,000,000 SALES AGREEMENT (Filed With SEC on April 22, 2016)
- SUBSCRIPTION AGREEMENT (Filed With SEC on March 14, 2016)
- ANTHERA PHARMACEUTICALS, INC. Deferred Compensation Election Form (Filed With SEC on March 14, 2016)
- * * * * (Filed With SEC on March 14, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2016)
- Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward, California 94545 July 8, 2015 (Filed With SEC on August 10, 2015)
- 3,333,334 Shares AntheraPharmaceuticals, Inc. Common Stock ($0.001 Par Value) EQUITYUNDERWRITING AGREEMENT (Filed With SEC on July 13, 2015)
- 5,555,556 Shares AntheraPharmaceuticals, Inc. Common Stock ($0.001 Par Value) EQUITYUNDERWRITING AGREEMENT (Filed With SEC on March 20, 2015)
- CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE... (Filed With SEC on March 16, 2015)
- ANTHERA PHARMACEUTICALS, INC. Deferred Compensation Election Form (Filed With SEC on March 16, 2015)
- CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE... (Filed With SEC on March 16, 2015)
- ANTHERA PHARMACEUTICALS, INC. STOCK PURCHASE AGREEMENT (Filed With SEC on March 16, 2015)
- SUBSCRIPTION AGREEMENT (Filed With SEC on March 16, 2015)
- SUBSCRIPTION AGREEMENT (Filed With SEC on March 16, 2015)
- PURCHASE AGREEMENT (Filed With SEC on March 16, 2015)
- LICENSE AGREEMENT (Filed With SEC on August 14, 2014)
- INCENTIVE STOCK OPTION AGREEMENT UNDER THE ANTHERA PHARMACEUTICALS, INC. 2013 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on March 28, 2014)
- NON-QUALIFIED STOCK OPTION AGREEMENT FOR NON-EMPLOYEE DIRECTORS UNDER THE ANTHERA PHARMACEUTICALS, INC. 2013 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on March 28, 2014)
- INCENTIVE STOCK OPTION AGREEMENT UNDER THE ANTHERA PHARMACEUTICALS, INC. 2013 STOCK OPTION AND INCENTIVE PLAN Option Holder: Date of Grant: Vesting Commencement Date: Number of... (Filed With SEC on March 28, 2014)
- RESTRICTED STOCK AWARD AGREEMENT UNDER THE ANTHERA PHARMACEUTICALS, INC. 2013 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on March 28, 2014)
- RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE ANTHERA PHARMACEUTICALS, INC. 2013 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on March 28, 2014)
- ANTHERA PHARMACEUTICALS, INC. Deferred Compensation Election Form (Filed With SEC on March 28, 2014)
- 655 MONTGOMERY STREET, SUITE 1190 SAN FRANCISCO, CA 94111-2658 (Filed With SEC on March 28, 2014)
- ANTHERA PHARMACEUTICALS, INC. $25,000,000 SALES AGREEMENT (Filed With SEC on November 15, 2013)
- ANTHERA PHARMACEUTICALS, INC. 2013 STOCK OPTION AND INCENTIVE PLAN SECTION 1.GENERAL PURPOSE OF THE PLAN; DEFINITIONS (Filed With SEC on August 6, 2013)
- CREDIT AND SECURITY AGREEMENT (Filed With SEC on April 5, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on April 5, 2013)
- ANTHERA PHARMACEUTICALS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on April 5, 2013)
- PURCHASE AGREEMENT (Filed With SEC on April 5, 2013)
- AMENDMENT NO. 2 TO ANTHERA PHARMACEUTICALS, INC. 2010 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on March 26, 2013)
- ANTHERA PHARMACEUTICALS, INC. DEFERRED COMPENSATION AGREEMENT (Filed With SEC on March 26, 2013)
- 60,606,061 Shares Anthera Pharmaceuticals, Inc. Common Stock ($0.001 Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on January 28, 2013)
- ANTHERA PHARMACEUTICALS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on November 8, 2012)
- 33,000,000 Shares Anthera Pharmaceuticals, Inc. Common Stock ($0.001 Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on July 20, 2012)
- CERTIFICATE OF AMENDMENT TO ANTHERA PHARMACEUTICALS, INC. 2010 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on August 12, 2011)
- Exhibit No (Filed With SEC on August 9, 2011)
- Exhibit No (Filed With SEC on August 9, 2011)
- Exhibit No (Filed With SEC on August 9, 2011)
- Underwriting Agreement, dated as of June 3, 2011, among Anthera Pharmaceuticals, Inc. and the underwriters named therein (Filed With SEC on June 3, 2011)
- CURRENT ASSETS (Filed With SEC on May 13, 2011)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on March 29, 2011)
- WARRANT AGREEMENT (Filed With SEC on March 29, 2011)
- the progress of, timing of and amount of expenses associated with our research, development and commercialization activities (Filed With SEC on March 7, 2011)
- the progress of, timing of and amount of expenses associated with our research, development and commercialization activities (Filed With SEC on March 7, 2011)
- convenient, at-home, patient-administered subcutaneous dosing (Filed With SEC on October 22, 2010)
- ANTHERA PHARMACEUTICALS, INC. (Filed With SEC on September 22, 2010)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 22, 2010)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 22, 2010)
- EMPLOYMENT AGREEMENT (Filed With SEC on June 4, 2010)
- CURRENT ASSETS (Filed With SEC on May 14, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on February 3, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on January 29, 2010)
- advancing A-002 through Phase 3 (Filed With SEC on November 16, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on November 16, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on November 16, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on November 16, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on November 16, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on November 16, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on October 19, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on October 19, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on October 19, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on October 19, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on October 19, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on October 19, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
- advancing A-002 through Phase 3 (Filed With SEC on September 15, 2009)
